1. Home
  2. BANX vs VTYX Comparison

BANX vs VTYX Comparison

Compare BANX & VTYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BANX
  • VTYX
  • Stock Information
  • Founded
  • BANX 2013
  • VTYX 2018
  • Country
  • BANX United States
  • VTYX United States
  • Employees
  • BANX N/A
  • VTYX N/A
  • Industry
  • BANX Trusts Except Educational Religious and Charitable
  • VTYX Medicinal Chemicals and Botanical Products
  • Sector
  • BANX Finance
  • VTYX Health Care
  • Exchange
  • BANX Nasdaq
  • VTYX Nasdaq
  • Market Cap
  • BANX 149.0M
  • VTYX 154.9M
  • IPO Year
  • BANX N/A
  • VTYX 2021
  • Fundamental
  • Price
  • BANX $21.08
  • VTYX $1.41
  • Analyst Decision
  • BANX
  • VTYX Buy
  • Analyst Count
  • BANX 0
  • VTYX 4
  • Target Price
  • BANX N/A
  • VTYX $11.33
  • AVG Volume (30 Days)
  • BANX 18.7K
  • VTYX 775.9K
  • Earning Date
  • BANX 03-25-2025
  • VTYX 02-27-2025
  • Dividend Yield
  • BANX 10.04%
  • VTYX N/A
  • EPS Growth
  • BANX N/A
  • VTYX N/A
  • EPS
  • BANX 2.35
  • VTYX N/A
  • Revenue
  • BANX $29,467,794.00
  • VTYX N/A
  • Revenue This Year
  • BANX N/A
  • VTYX N/A
  • Revenue Next Year
  • BANX N/A
  • VTYX N/A
  • P/E Ratio
  • BANX $8.90
  • VTYX N/A
  • Revenue Growth
  • BANX 2.74
  • VTYX N/A
  • 52 Week Low
  • BANX $17.91
  • VTYX $1.34
  • 52 Week High
  • BANX $21.67
  • VTYX $8.12
  • Technical
  • Relative Strength Index (RSI)
  • BANX 49.56
  • VTYX 36.94
  • Support Level
  • BANX $20.80
  • VTYX $1.36
  • Resistance Level
  • BANX $21.31
  • VTYX $1.50
  • Average True Range (ATR)
  • BANX 0.26
  • VTYX 0.11
  • MACD
  • BANX -0.01
  • VTYX 0.01
  • Stochastic Oscillator
  • BANX 51.85
  • VTYX 25.45

About BANX ArrowMark Financial Corp.

ArrowMark Financial Corp is a non-diversified, closed-end management investment company. Its objective is to provide stockholders with current income, and to a lesser extent capital appreciation. The company's investments in various portfolios such as debt securities, Trust Preferred and Preferred Securities, preferred securities, exchange-traded funds, money market funds, and others.

About VTYX Ventyx Biosciences Inc.

Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.

Share on Social Networks: